Tocqueville Asset Management’s Agios Pharmaceuticals AGIO Stock Holding History

Tocqueville Asset Management’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-13,600	Closed	-$570K	–	825
2016 Q2	$570K	Sell	13,600 -2,525	-16%	-$125K	0.01%	612
2016 Q1	$655K	Sell	16,125 -3,275	-17%	-$140K	0.01%	571
2015 Q4	$1.26M	Sell	19,400 -200	-1%	-$13.1K	0.02%	500
2015 Q3	$1.38M	Buy	19,600 +6,725	+52%	+$657K	0.02%	497
2015 Q2	$1.43M	Buy	12,875 +3,975	+45%	+$428K	0.02%	508
2015 Q1	$839K	Buy	+8,900	New	+$997K	0.01%	616

Other funds holding AGIO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Tocqueville Asset Management's AGIO Position: Q3 2016 in Review

Tocqueville Asset Management sold out of Agios Pharmaceuticals (AGIO) in Q3 2016, closing a stake of 13,600 shares — an estimated $570K sold.

Tocqueville Asset Management first reported a position in AGIO in Q1 2015 and held it in 6 quarters. The position peaked at $1.43M in Q2 2015. 163 funds tracked by Wall St. Rank hold AGIO as of Q3 2016.

Tocqueville Asset Management reported no remaining Agios Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
Tocqueville Asset Management sold 13,600 Agios Pharmaceuticals shares in Q3 2016, an estimated $570K.
Tocqueville Asset Management first reported a position in Agios Pharmaceuticals in Q1 2015 and held it in 6 quarters.
Tocqueville Asset Management's Agios Pharmaceuticals position peaked at $1.43M in Q2 2015.
163 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2016.

Based on Tocqueville Asset Management's 13F filing for Q3 2016, filed 31 Oct 2016.